Sai Life Sciences Limited (BOM:544306)
India · Delayed Price · Currency is INR 794.25
-10.60 (-1.32%)
At close: Aug 5, 2025
Sai Life Sciences Revenue
In the fiscal year ending March 31, 2025, Sai Life Sciences had annual revenue of 16.95B INR with 15.66% growth. Sai Life Sciences had revenue of 5.80B in the quarter ending March 31, 2025, with 31.94% growth.
Revenue
16.95B
Revenue Growth
+15.66%
P/S Ratio
9.05
Revenue / Employee
6.10M
Employees
2,845
Market Cap
172.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 16.95B | 2.29B | 15.66% |
| Mar 31, 2024 | 14.65B | 2.48B | 20.38% |
| Mar 31, 2023 | 12.17B | 3.48B | 39.97% |
| Mar 31, 2022 | 8.70B | 1.10B | 14.44% |
| Mar 31, 2021 | 7.60B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,429.39B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |